FDA panel debates lower-dose Moderna COVID booster

U.S. health advisers are debating if those who received Moderna COVID-19 vaccinations should get a booster at half the original dosage. But they stress the priority is still to get shots to the 66 million unvaccinated Americans who are eligible. (Oct. 14)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting